Beijing Xinyi Biotechnology
Beijing Xinyi Biotechnology is manufacturing micro-droplet digital PCR and in vitro diagnostic reagents. Products include drop maker sample preparation, chip reader, PCR universal amplification reagent, genetic testing kit (for scientific research only), micro-droplet detection oil, nucleic acid extraction reagent (magnetic beads method), etc. Founded in 2015, headquartered in Haidian, China. The company has raised…
Funding snapshot
About
Beijing Xinyi Biotechnology is manufacturing micro-droplet digital PCR and in vitro diagnostic reagents. Products include drop maker sample preparation, chip reader, PCR universal amplification reagent, genetic testing kit (for scientific research only), micro-droplet detection oil, nucleic acid extraction reagent (magnetic beads method), etc. Founded in 2015, headquartered in Haidian, China. The company has raised $23.2M in funding at the series b stage. The company operates in Life Sciences > Life Sciences Platforms and Tools, Life Sciences > Genomics, Life Sciences > Clinical Genomics. Its business models include Genomics > Applied Genomics > Clinical Genomics > Diagnostics > Amplification-based > PCR, Life Sciences Platforms and Tools > Instruments > Genomics > PCR. Founded in 2015. Headquartered in China, Haidian. The company has raised funding at the Series B stage. Backed by investors including Jiuzhi Capital, Huade Capital Management Group, Lilly Asia Ventures, China Growth Capital, Hillhouse, Sino-German High-Tech Fund.
Business model
Genomics > Applied Genomics > Clinical Genomics > Diagnostics > Amplification-based > PCR,
Life Sciences Platforms and Tools > Instruments > Genomics > PCR
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.
Raising like Beijing Xinyi Biotechnology?
Analyze your pitch deck before your next raise.
Analyze My Deck →